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Introduction
The overall aim of this project is to establish how post-transcriptionally silencing 
members of the insulin gene family affects neuronal aberrations of mechanosensory 
neurons. Our overall goal is to assay aberrant neuronal morphology and touch 
response in wild type and neurodegenerative models, as well as hungtingtin protein 
aggregation in a neurodegeneration model of C. elegans.
Neurodegenerative diseases such as Huntington’s, Alzheimer’s and Parkinson’s result 
in accelerated neuronal aging characterized by a gradual loss of structure and 
function of neurons, impaired motor control, and decreased cognitive ability. 
Huntington’s disease (HD) is the result of a genetic mutation resulting in an expansion 
of CAG trinucleotide repeats in the first exon of the huntingtin (HTT) gene giving way 
to polyglutamine (polyQ) chains leading to aggregate formation, neuronal dystrophy 
and severe dysfunction.
In humans, more than 36 repeats may result in toxicity and the onset of Huntington’s 
disease. Our HD model has 128 repeats and expresses the fluorescently labeled toxic 
(polyQ128) huntingtin in the mechanosensory neurons of the model system, 
Caenorhabditis elegans. 
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Figure 1 A simplied diagram of Caenorhabditis elegans with mechanosensory neurons of interest labeled. Models are transgenic mutants
with uorescently labeled mechanosensory neurons and aggregates.  Overexpression of SID-1 channels allows for RNAi sensitivity. Also listed 
are the genotypic nomenclature for  the Huntington’s disease and wild type models respectively.
So far we have seen a signicant impact on neuronal morphology by knocking
down insulin like peptides 2, 3, 5 and 7. Our primary goal is to complete this 
screen for all 40 insulin like peptides in C. elegans. After the completion of the 
screen, more in depth study on specic and interesting peptides. We are also 
interested in how these insulins like peptides interact with each other. 
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Figure 2 Examples of neuronal aberrations that appear in aging neurons. Normal brain aging is characterized by synaptic deterioration and
changes in the cytoskeletal structures of neurons (B.A. Yankner et al. 2008). These structural changes may lead to an increase in cognitive 
decline and contribute to neurodegenerative diseases such as Alzheimer’s and Huntington’s disease (Knobloch and Mansuy, 2008).
Insulin Signaling 
The C. elegans IIS pathway 
includes insulin-like peptides
(ILP), a single receptor (DAF-2),
and a downstream signaling 
cascade which inuences the 
DAF-16 transcription factor. 
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Figure 3 Insulin-like peptide signaling
pathway in C. elegans. The C. elegans IIS 
pathway includes insulin-like peptides, a single
receptor (DAF-2), and a downstream signaling
cascade which inuences the DAF-16
transcription factor. Loss-of-function mutations 
in daf-2 aect lifespan, reproduction,metabolism, 
stress and dauer formation, and a complete loss 
of the receptor is lethal 
(Ritter, Ashlyn D et al. 2013).
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Figure 5 Mean aberrations in whole worm and cell type in (A/C) wild type and (B/D) neurodegenerative models.
A) Mean aberrations of cell types versus treatment in wild type (overall P < 0.001, ANOVA PLML P = 0.001, ANOVA ALMR P = 0.012).
B) Mean aberrations of cell types versus treatment in neurodegenerative model (overall P < 0.014, ANOVA ALML cell type L4440 against ins-7
P < 0.011 ).
C) Mean aberrations of whole worm versus treatment in wild type (P < 0.001).
D) Mean aberrations of whole worm versus treatment in neurodegenerative model (P = 0.067).
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Figure 4 Schematic and description of screen methodology used in this
project.
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1. L4440 vector contains regions for specic insulin
    peptide, antibiotic resistance, and other useful tools.
2. The vector is incorporated into E. coli (HT115).
3. IPTG in the plate media activates the synthesis of
    dsRNA as the bacteria grows into a lawn.
4. RNAi sensitive worms take up the vector while feeding
on E. coli.
5. Over expression of SID-1 channels results in dsRNA
entering the cell. Inside the cell dsRNA is converted
into ssRNA.
6. The ssRNA is complexed into the RNA Induced Silencing
    Complex (RISC).
7. RISC pairs to complementary mRNA strand
targeting it for destruction.
8. RISC degrades mRNA - peptide never forms.
9. We score and image 5 day old adult worms under
    uorescent microscope.
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Neuronal morphology is
 affected by the insulin-IGF signaling
 pathway, specifically through
 differential  insulin-like
peptide expression. 
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